Lacunar-Brain Infarction Cerebral Hyperactivity And Atorvastatin Trial. A Placebo-Controlled Trial Of High-Dose Atorvastatin In Patients With Cerebral Small Vessel Disease

Trial Profile

Lacunar-Brain Infarction Cerebral Hyperactivity And Atorvastatin Trial. A Placebo-Controlled Trial Of High-Dose Atorvastatin In Patients With Cerebral Small Vessel Disease

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 May 2009

At a glance

  • Drugs Atorvastatin (Primary)
  • Indications Cerebrovascular disorders; Stroke
  • Focus Pharmacodynamics; Therapeutic Use
  • Acronyms LA-BICHAT
  • Sponsors Pfizer
  • Most Recent Events

    • 22 May 2009 New trial record.
    • 01 May 2009 Results of reported in Stroke.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top